Company: BIVIW
Filing Date: 2025-10-06
Form Type: POS AM
Source: 0001520138-25-000294
Chunk: 32

Company: BIOVIE INC.
Filing Date: 2025-10-06
Form: POS AM
Chunk 32
---
 is not necessarily complete. If
a contract or document has been filed as an exhibit to the registration statement, please see the copy of the contract or document that
has been filed. Each statement is this prospectus relating to a contract or document filed as an exhibit is qualified in all respects
by the filed exhibit. The SEC maintains an Internet website that contains reports, proxy statements and other information about issuers,
like us, that file electronically with the SEC. The address of that website is www.sec.gov.

We are subject to the information and reporting requirements
of the Securities Exchange Act of 1934, as amended, and, in accordance with this law, file periodic reports, proxy statements and other
information with the SEC. These periodic reports, proxy statements and other information are available on the website of the SEC referred
to above. We maintain a website at https://bioviepharma.com/. Information found on, or accessible through, our website is not a part of,
and is not incorporated into, this prospectus, and you should not consider it part of this prospectus.

<div align='center'>Incorporation of Documents by Reference</div>

The SEC allows us to incorporate by reference the
information we file with it, which means that we can disclose important information to you by referring you to another document that we
have filed separately with the SEC. You should read the information incorporated by reference because it is an important part of this
prospectus. Information in this prospectus supersedes information incorporated by reference that we filed with the SEC prior to the date
of this prospectus, while information that we file later with the SEC will automatically update and supersede the information in this
prospectus. We incorporate by reference into this prospectus and the registration statement of which this prospectus is a part the information
or documents listed below that we have filed with the SEC (Commission File No. 001-39015):

| · | the                                                                                                                                   
 description of our Common Stock contained in our registration on Form 8-A (File No. 001-39015) filed with the SEC on August 25, 2020, 
 including any amendment or report filed for the purpose of updating such description.                                                 |

We also incorporate by reference any future filings
(other than current reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are related to such
items unless such Form 8-K expressly provides to